Item | Property | Value | Comments |
---|
include | http://hl7.org/fhir/sid/cvx | | 20220412 | |
Concept | 01 | diphtheria, tetanus toxoids and pertussis vaccine | |
Concept | 02 | trivalent poliovirus vaccine, live, oral | |
Concept | 03 | measles, mumps and rubella virus vaccine | |
Concept | 04 | measles and rubella virus vaccine | |
Concept | 05 | measles virus vaccine | |
Concept | 06 | rubella virus vaccine | |
Concept | 07 | mumps virus vaccine | |
Concept | 08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | |
Concept | 09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
Concept | 10 | poliovirus vaccine, inactivated | |
Concept | 100 | pneumococcal conjugate vaccine, 7 valent | |
Concept | 101 | typhoid Vi capsular polysaccharide vaccine | |
Concept | 102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | |
Concept | 103 | meningococcal C conjugate vaccine | |
Concept | 104 | hepatitis A and hepatitis B vaccine | |
Concept | 105 | vaccinia (smallpox) vaccine, diluted | |
Concept | 106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | |
Concept | 107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation | |
Concept | 108 | meningococcal ACWY vaccine, unspecified formulation | |
Concept | 109 | pneumococcal vaccine, unspecified formulation | |
Concept | 11 | pertussis vaccine | |
Concept | 110 | DTaP-hepatitis B and poliovirus vaccine | |
Concept | 111 | influenza virus vaccine, live, attenuated, for intranasal use | |
Concept | 112 | tetanus toxoid, unspecified formulation | |
Concept | 113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
Concept | 114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) | |
Concept | 115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | |
Concept | 116 | rotavirus, live, pentavalent vaccine | |
Concept | 117 | varicella zoster immune globulin (Investigational New Drug) | |
Concept | 118 | human papilloma virus vaccine, bivalent | |
Concept | 119 | rotavirus, live, monovalent vaccine | |
Concept | 12 | diphtheria antitoxin | |
Concept | 120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
Concept | 121 | zoster vaccine, live | |
Concept | 122 | rotavirus vaccine, unspecified formulation | |
Concept | 123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) | |
Concept | 125 | Novel Influenza-H1N1-09, live virus for nasal administration | |
Concept | 126 | Novel influenza-H1N1-09, preservative-free, injectable | |
Concept | 127 | Novel influenza-H1N1-09, injectable | |
Concept | 128 | Novel influenza-H1N1-09, all formulations | |
Concept | 129 | Japanese Encephalitis vaccine, unspecified formulation | |
Concept | 13 | tetanus immune globulin | |
Concept | 130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated | |
Concept | 131 | Historical record of a typhus vaccination | |
Concept | 132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. | |
Concept | 133 | pneumococcal conjugate vaccine, 13 valent | |
Concept | 134 | Japanese Encephalitis vaccine for intramuscular administration | |
Concept | 135 | influenza, high dose seasonal, preservative-free | |
Concept | 136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) | |
Concept | 137 | HPV, unspecified formulation | |
Concept | 138 | tetanus and diphtheria toxoids, not adsorbed, for adult use | |
Concept | 139 | Td(adult) unspecified formulation | |
Concept | 14 | immune globulin, unspecified formulation | |
Concept | 140 | Influenza, seasonal, injectable, preservative free | |
Concept | 141 | Influenza, seasonal, injectable | |
Concept | 142 | tetanus toxoid, not adsorbed | |
Concept | 143 | Adenovirus, type 4 and type 7, live, oral | |
Concept | 144 | seasonal influenza, intradermal, preservative free | |
Concept | 147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) | |
Concept | 148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | |
Concept | 149 | influenza, live, intranasal, quadrivalent | |
Concept | 15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE | |
Concept | 150 | Influenza, injectable, quadrivalent, preservative free | |
Concept | 151 | influenza nasal, unspecified formulation | |
Concept | 152 | Pneumococcal Conjugate, unspecified formulation | |
Concept | 153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free | |
Concept | 155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free | |
Concept | 156 | Rho(D) Immune globulin- IV or IM | |
Concept | 157 | Rho(D) Immune globulin - IM | |
Concept | 158 | influenza, injectable, quadrivalent, contains preservative | |
Concept | 159 | Rho(D) Unspecified formulation | |
Concept | 16 | influenza virus vaccine, whole virus | |
Concept | 160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 | |
Concept | 161 | Influenza, injectable,quadrivalent, preservative free, pediatric | |
Concept | 162 | meningococcal B vaccine, fully recombinant | |
Concept | 163 | meningococcal B vaccine, recombinant, OMV, adjuvanted | |
Concept | 164 | meningococcal B, unspecified formulation | |
Concept | 165 | Human Papillomavirus 9-valent vaccine | |
Concept | 166 | influenza, intradermal, quadrivalent, preservative free, injectable | |
Concept | 167 | meningococcal vaccine of unknown formulation and unknown serogroups | |
Concept | 168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free | |
Concept | 169 | Hep A, live attenuated-IM | |
Concept | 17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation | |
Concept | 170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
Concept | 171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent | |
Concept | 172 | cholera, WC-rBS | |
Concept | 173 | cholera, BivWC | |
Concept | 174 | cholera, live attenuated | |
Concept | 175 | Human Rabies vaccine from human diploid cell culture | |
Concept | 176 | Human rabies vaccine from Chicken fibroblast culture | |
Concept | 177 | pneumococcal conjugate vaccine, 10 valent | |
Concept | 178 | Non-US bivalent oral polio vaccine (types 1 and 3) | |
Concept | 179 | Non-US monovalent oral polio vaccine, unspecified formulation | |
Concept | 18 | rabies vaccine, for intramuscular injection RETIRED CODE | |
Concept | 180 | tetanus immune globulin | |
Concept | 181 | anthrax immune globulin | |
Concept | 182 | Oral Polio Vaccine, Unspecified formulation | |
Concept | 183 | Yellow fever vaccine alternative formulation | |
Concept | 184 | Yellow fever vaccine, unspecified formulation | |
Concept | 185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free | |
Concept | 186 | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative | |
Concept | 187 | zoster vaccine recombinant | |
Concept | 188 | zoster vaccine, unspecified formulation | |
Concept | 189 | Hepatitis B vaccine (recombinant), CpG adjuvanted | |
Concept | 19 | Bacillus Calmette-Guerin vaccine | |
Concept | 20 | diphtheria, tetanus toxoids and acellular pertussis vaccine | |
Concept | 21 | varicella virus vaccine | |
Concept | 22 | DTP-Haemophilus influenzae type b conjugate vaccine | |
Concept | 23 | plague vaccine | |
Concept | 24 | anthrax vaccine | |
Concept | 25 | typhoid vaccine, live, oral | |
Concept | 26 | cholera vaccine, unspecified formulation | |
Concept | 27 | botulinum antitoxin | |
Concept | 28 | diphtheria and tetanus toxoids, adsorbed for pediatric use | |
Concept | 29 | cytomegalovirus immune globulin, intravenous | |
Concept | 30 | hepatitis B immune globulin | |
Concept | 31 | hepatitis A vaccine, pediatric dosage, unspecified formulation | |
Concept | 32 | meningococcal polysaccharide vaccine (MPSV4) | |
Concept | 33 | pneumococcal polysaccharide vaccine, 23 valent | |
Concept | 34 | rabies immune globulin | |
Concept | 35 | tetanus toxoid, adsorbed | |
Concept | 36 | varicella zoster immune globulin | |
Concept | 37 | yellow fever vaccine | |
Concept | 38 | rubella and mumps virus vaccine | |
Concept | 39 | Japanese Encephalitis Vaccine SC | |
Concept | 40 | rabies vaccine, for intradermal injection | |
Concept | 41 | typhoid vaccine, parenteral, other than acetone-killed, dried | |
Concept | 42 | hepatitis B vaccine, adolescent/high risk infant dosage | |
Concept | 43 | hepatitis B vaccine, adult dosage | |
Concept | 44 | hepatitis B vaccine, dialysis patient dosage | |
Concept | 45 | hepatitis B vaccine, unspecified formulation | |
Concept | 46 | Haemophilus influenzae type b vaccine, PRP-D conjugate | |
Concept | 47 | Haemophilus influenzae type b vaccine, HbOC conjugate | |
Concept | 48 | Haemophilus influenzae type b vaccine, PRP-T conjugate | |
Concept | 49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | |
Concept | 50 | DTaP-Haemophilus influenzae type b conjugate vaccine | |
Concept | 51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | |
Concept | 52 | hepatitis A vaccine, adult dosage | |
Concept | 53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | |
Concept | 54 | adenovirus vaccine, type 4, live, oral | |
Concept | 55 | adenovirus vaccine, type 7, live, oral | |
Concept | 62 | human papilloma virus vaccine, quadrivalent | |
Concept | 66 | Lyme disease vaccine | |
Concept | 69 | parainfluenza-3 virus vaccine | |
Concept | 71 | respiratory syncytial virus immune globulin, intravenous | |
Concept | 74 | rotavirus, live, tetravalent vaccine | |
Concept | 75 | vaccinia (smallpox) vaccine | |
Concept | 76 | Staphylococcus bacteriophage lysate | |
Concept | 77 | tick-borne encephalitis vaccine | |
Concept | 78 | tularemia vaccine | |
Concept | 79 | vaccinia immune globulin | |
Concept | 80 | Venezuelan equine encephalitis, live, attenuated | |
Concept | 801 | AS03 Adjuvant | |
Concept | 81 | Venezuelan equine encephalitis, inactivated | |
Concept | 82 | adenovirus vaccine, unspecified formulation | |
Concept | 83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | |
Concept | 84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | |
Concept | 85 | hepatitis A vaccine, unspecified formulation | |
Concept | 86 | immune globulin, intramuscular | |
Concept | 87 | immune globulin, intravenous | |
Concept | 88 | influenza virus vaccine, unspecified formulation | |
Concept | 89 | poliovirus vaccine, unspecified formulation | |
Concept | 90 | rabies vaccine, unspecified formulation | |
Concept | 91 | typhoid vaccine, unspecified formulation | |
Concept | 92 | Venezuelan equine encephalitis vaccine, unspecified formulation | |
Concept | 93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | |
Concept | 94 | measles, mumps, rubella, and varicella virus vaccine | |
Concept | 95 | tuberculin skin test; old tuberculin, multipuncture device | |
Concept | 96 | tuberculin skin test; purified protein derivative solution, intradermal | |
Concept | 97 | tuberculin skin test; purified protein derivative, multipuncture device | |
Concept | 98 | tuberculin skin test; unspecified formulation | |
Concept | 998 | no vaccine administered | |
Concept | | 146 | | Version: Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. | |
Concept | | 190 | | Version: Typhoid conjugate vaccine (non-US) | |
Concept | | 191 | | Version: meningococcal A polysaccharide vaccine (non-US) | |
Concept | | 192 | | Version: meningococcal AC polysaccharide vaccine (non-US) | |
Concept | | 193 | | Version: hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) | |
Concept | | 194 | | Version: influenza, Southern Hemisphere, unspecified formulation | |
Concept | | 195 | | Version: Diphtheria, Tetanus, Poliomyelitis adsorbed | |
Concept | | 196 | | Version: tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified | |
Concept | | 197 | | Version: influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free | |
Concept | | 198 | | Version: Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) | |
Concept | | 200 | | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free | |
Concept | | 201 | | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative | |
Concept | | 202 | | Version: influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative | |
Concept | | 203 | | Version: meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free | |
Concept | | 204 | | Version: Ebola Zaire vaccine, live, recombinant, 1mL dose | |
Concept | | 205 | | Version: influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free | |
Concept | | 206 | | Version: smallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile) | |
Concept | | 207 | | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose | |
Concept | | 208 | | Version: SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose | |
Concept | | 210 | | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL | |
Concept | | 211 | | Version: SARS-COV-2 (COVID-19) vaccine, Subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL per dose | |
Concept | | 212 | | Version: SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL | |
Concept | | 213 | | Version: SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | |
Concept | | 214 | | Version: Ebola, unspecified | |
Concept | | 56 | | Version: dengue fever vaccine | |
Code | Display | Comments |
---|
01 | diphtheria, tetanus toxoids and pertussis vaccine | |
02 | trivalent poliovirus vaccine, live, oral | |
03 | measles, mumps and rubella virus vaccine | |
04 | measles and rubella virus vaccine | |
05 | measles virus vaccine | |
06 | rubella virus vaccine | |
07 | mumps virus vaccine | |
08 | hepatitis B vaccine, pediatric or pediatric/adolescent dosage | |
09 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (2 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
10 | poliovirus vaccine, inactivated | |
100 | pneumococcal conjugate vaccine, 7 valent | |
101 | typhoid Vi capsular polysaccharide vaccine | |
102 | DTP- Haemophilus influenzae type b conjugate and hepatitis b vaccine | |
103 | meningococcal C conjugate vaccine | |
104 | hepatitis A and hepatitis B vaccine | |
105 | vaccinia (smallpox) vaccine, diluted | |
106 | diphtheria, tetanus toxoids and acellular pertussis vaccine, 5 pertussis antigens | |
107 | diphtheria, tetanus toxoids and acellular pertussis vaccine, unspecified formulation | |
108 | meningococcal ACWY vaccine, unspecified formulation | |
109 | pneumococcal vaccine, unspecified formulation | |
11 | pertussis vaccine | |
110 | DTaP-hepatitis B and poliovirus vaccine | |
111 | influenza virus vaccine, live, attenuated, for intranasal use | |
112 | tetanus toxoid, unspecified formulation | |
113 | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use (5 Lf of tetanus toxoid and 2 Lf of diphtheria toxoid) | |
114 | meningococcal polysaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4P) | |
115 | tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine, adsorbed | |
116 | rotavirus, live, pentavalent vaccine | |
117 | varicella zoster immune globulin (Investigational New Drug) | | |
118 | human papilloma virus vaccine, bivalent | |
119 | rotavirus, live, monovalent vaccine | |
12 | diphtheria antitoxin | |
120 | diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
121 | zoster vaccine, live | |
122 | rotavirus vaccine, unspecified formulation | |
123 | influenza virus vaccine, H5N1, A/Vietnam/1203/2004 (national stockpile) | |
125 | Novel Influenza-H1N1-09, live virus for nasal administration | |
126 | Novel influenza-H1N1-09, preservative-free, injectable | |
127 | Novel influenza-H1N1-09, injectable | |
128 | Novel influenza-H1N1-09, all formulations | |
129 | Japanese Encephalitis vaccine, unspecified formulation | |
13 | tetanus immune globulin | |
130 | Diphtheria, tetanus toxoids and acellular pertussis vaccine, and poliovirus vaccine, inactivated | |
131 | Historical record of a typhus vaccination | |
132 | Historical diphtheria and tetanus toxoids and acellular pertussis, poliovirus, Haemophilus b conjugate and hepatitis B (recombinant) vaccine. | |
133 | pneumococcal conjugate vaccine, 13 valent | |
134 | Japanese Encephalitis vaccine for intramuscular administration | |
135 | influenza, high dose seasonal, preservative-free | |
136 | meningococcal oligosaccharide (groups A, C, Y and W-135) diphtheria toxoid conjugate vaccine (MCV4O) | |
137 | HPV, unspecified formulation | |
138 | tetanus and diphtheria toxoids, not adsorbed, for adult use | |
139 | Td(adult) unspecified formulation | |
14 | immune globulin, unspecified formulation | |
140 | Influenza, seasonal, injectable, preservative free | |
141 | Influenza, seasonal, injectable | |
142 | tetanus toxoid, not adsorbed | |
143 | Adenovirus, type 4 and type 7, live, oral | |
144 | seasonal influenza, intradermal, preservative free | |
147 | Meningococcal, MCV4, unspecified conjugate formulation(groups A, C, Y and W-135) | |
148 | Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid Conjugate Vaccine | |
149 | influenza, live, intranasal, quadrivalent | |
15 | influenza virus vaccine, split virus (incl. purified surface antigen)-retired CODE | |
150 | Influenza, injectable, quadrivalent, preservative free | |
151 | influenza nasal, unspecified formulation | |
152 | Pneumococcal Conjugate, unspecified formulation | |
153 | Influenza, injectable, Madin Darby Canine Kidney, preservative free | |
155 | Seasonal, trivalent, recombinant, injectable influenza vaccine, preservative free | |
156 | Rho(D) Immune globulin- IV or IM | |
157 | Rho(D) Immune globulin - IM | |
158 | influenza, injectable, quadrivalent, contains preservative | |
159 | Rho(D) Unspecified formulation | |
16 | influenza virus vaccine, whole virus | |
160 | Influenza A monovalent (H5N1), adjuvanted, National stockpile 2013 | |
161 | Influenza, injectable,quadrivalent, preservative free, pediatric | |
162 | meningococcal B vaccine, fully recombinant | |
163 | meningococcal B vaccine, recombinant, OMV, adjuvanted | |
164 | meningococcal B, unspecified formulation | |
165 | Human Papillomavirus 9-valent vaccine | |
166 | influenza, intradermal, quadrivalent, preservative free, injectable | |
167 | meningococcal vaccine of unknown formulation and unknown serogroups | |
168 | Seasonal trivalent influenza vaccine, adjuvanted, preservative free | |
169 | Hep A, live attenuated-IM | |
17 | Haemophilus influenzae type b vaccine, conjugate unspecified formulation | |
170 | non-US diphtheria, tetanus toxoids and acellular pertussis vaccine, Haemophilus influenzae type b conjugate, and poliovirus vaccine, inactivated (DTaP-Hib-IPV) | |
171 | Influenza, injectable, Madin Darby Canine Kidney, preservative free, quadrivalent | |
172 | cholera, WC-rBS | |
173 | cholera, BivWC | |
174 | cholera, live attenuated | |
175 | Human Rabies vaccine from human diploid cell culture | |
176 | Human rabies vaccine from Chicken fibroblast culture | |
177 | pneumococcal conjugate vaccine, 10 valent | |
178 | Non-US bivalent oral polio vaccine (types 1 and 3) | |
179 | Non-US monovalent oral polio vaccine, unspecified formulation | |
18 | rabies vaccine, for intramuscular injection RETIRED CODE | |
180 | tetanus immune globulin | |
181 | anthrax immune globulin | |
182 | Oral Polio Vaccine, Unspecified formulation | |
183 | Yellow fever vaccine alternative formulation | |
184 | Yellow fever vaccine, unspecified formulation | |
185 | Seasonal, quadrivalent, recombinant, injectable influenza vaccine, preservative free | |
186 | Influenza, injectable, Madin Darby Canine Kidney, quadrivalent with preservative | |
187 | zoster vaccine recombinant | |
188 | zoster vaccine, unspecified formulation | |
189 | Hepatitis B vaccine (recombinant), CpG adjuvanted | |
19 | Bacillus Calmette-Guerin vaccine | |
20 | diphtheria, tetanus toxoids and acellular pertussis vaccine | |
21 | varicella virus vaccine | |
22 | DTP-Haemophilus influenzae type b conjugate vaccine | |
23 | plague vaccine | |
24 | anthrax vaccine | |
25 | typhoid vaccine, live, oral | |
26 | cholera vaccine, unspecified formulation | |
27 | botulinum antitoxin | |
28 | diphtheria and tetanus toxoids, adsorbed for pediatric use | |
29 | cytomegalovirus immune globulin, intravenous | |
30 | hepatitis B immune globulin | |
31 | hepatitis A vaccine, pediatric dosage, unspecified formulation | |
32 | meningococcal polysaccharide vaccine (MPSV4) | |
33 | pneumococcal polysaccharide vaccine, 23 valent | |
34 | rabies immune globulin | |
35 | tetanus toxoid, adsorbed | |
36 | varicella zoster immune globulin | |
37 | yellow fever vaccine | |
38 | rubella and mumps virus vaccine | |
39 | Japanese Encephalitis Vaccine SC | |
40 | rabies vaccine, for intradermal injection | |
41 | typhoid vaccine, parenteral, other than acetone-killed, dried | |
42 | hepatitis B vaccine, adolescent/high risk infant dosage | |
43 | hepatitis B vaccine, adult dosage | |
44 | hepatitis B vaccine, dialysis patient dosage | |
45 | hepatitis B vaccine, unspecified formulation | |
46 | Haemophilus influenzae type b vaccine, PRP-D conjugate | |
47 | Haemophilus influenzae type b vaccine, HbOC conjugate | |
48 | Haemophilus influenzae type b vaccine, PRP-T conjugate | |
49 | Haemophilus influenzae type b vaccine, PRP-OMP conjugate | |
50 | DTaP-Haemophilus influenzae type b conjugate vaccine | |
51 | Haemophilus influenzae type b conjugate and Hepatitis B vaccine | |
52 | hepatitis A vaccine, adult dosage | |
53 | typhoid vaccine, parenteral, acetone-killed, dried (U.S. military) | |
54 | adenovirus vaccine, type 4, live, oral | |
55 | adenovirus vaccine, type 7, live, oral | |
62 | human papilloma virus vaccine, quadrivalent | |
66 | Lyme disease vaccine | |
69 | parainfluenza-3 virus vaccine | |
71 | respiratory syncytial virus immune globulin, intravenous | |
74 | rotavirus, live, tetravalent vaccine | |
75 | vaccinia (smallpox) vaccine | |
76 | Staphylococcus bacteriophage lysate | |
77 | tick-borne encephalitis vaccine | Tick-borne encephalitis vaccine (non-US) | - display changed from left to right
|
78 | tularemia vaccine | |
79 | vaccinia immune globulin | |
80 | Venezuelan equine encephalitis, live, attenuated | |
801 | AS03 Adjuvant | |
81 | Venezuelan equine encephalitis, inactivated | |
82 | adenovirus vaccine, unspecified formulation | |
83 | hepatitis A vaccine, pediatric/adolescent dosage, 2 dose schedule | |
84 | hepatitis A vaccine, pediatric/adolescent dosage, 3 dose schedule | |
85 | hepatitis A vaccine, unspecified formulation | |
86 | immune globulin, intramuscular | |
87 | immune globulin, intravenous | |
88 | influenza virus vaccine, unspecified formulation | |
89 | poliovirus vaccine, unspecified formulation | |
90 | rabies vaccine, unspecified formulation | |
91 | typhoid vaccine, unspecified formulation | |
92 | Venezuelan equine encephalitis vaccine, unspecified formulation | |
93 | respiratory syncytial virus monoclonal antibody (palivizumab), intramuscular | |
94 | measles, mumps, rubella, and varicella virus vaccine | |
95 | tuberculin skin test; old tuberculin, multipuncture device | |
96 | tuberculin skin test; purified protein derivative solution, intradermal | |
97 | tuberculin skin test; purified protein derivative, multipuncture device | |
98 | tuberculin skin test; unspecified formulation | |
998 | no vaccine administered | |
146 | | Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate (Meningococcal Protein Conjugate), and Hepatitis B (Recombinant) Vaccine. | |
190 | | Typhoid conjugate vaccine (non-US) | |
191 | | meningococcal A polysaccharide vaccine (non-US) | |
192 | | meningococcal AC polysaccharide vaccine (non-US) | |
193 | | hepatitis A and hepatitis B vaccine, pediatric/adolescent (non-US) | |
194 | | influenza, Southern Hemisphere, unspecified formulation | |
195 | | Diphtheria, Tetanus, Poliomyelitis adsorbed | |
196 | | tetanus and diphtheria toxoids, adsorbed, preservative free, for adult use, Lf unspecified | |
197 | | influenza, high-dose seasonal, quadrivalent, .7mL dose, preservative free | |
198 | | Diphtheria, pertussis, tetanus, hepatitis B, Haemophilus Influenza Type b, (Pentavalent) | |
200 | | influenza, seasonal, Southern Hemisphere, quadrivalent, pediatric 0.25mL dose, preservative free | |
201 | | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, no preservative | |
202 | | influenza, seasonal, Southern Hemisphere, quadrivalent, 0.5mL dose, with preservative | |
203 | | meningococcal polysaccharide (groups A, C, Y, W-135) tetanus toxoid conjugate vaccine .5mL dose, preservative free | |
204 | | Ebola Zaire vaccine, live, recombinant, 1mL dose | |
205 | | influenza, seasonal vaccine, quadrivalent, adjuvanted, .5mL dose, preservative free | |
206 | | Vaccinia, smallpox monkeypox vaccine, live attenuated, preservative free (National Stockpile) | |
207 | | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose | |
208 | | SARS-COV-2 (COVID-19) vaccine, mRNA, spike protein, LNP, preservative free, 30 mcg/0.3mL dose | |
210 | | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-ChAdOx1, preservative free, 0.5 mL | |
211 | | SARS-COV-2 (COVID-19) vaccine, subunit, recombinant spike protein-nanoparticle+Matrix-M1 Adjuvant, preservative free, 0.5mL dose | |
212 | | SARS-COV-2 (COVID-19) vaccine, vector non-replicating, recombinant spike protein-Ad26, preservative free, 0.5 mL | |
213 | | SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED | |
214 | | Ebola, unspecified | |
56 | | dengue fever vaccine | |